{"id":"NCT04437433","sponsor":"AbbVie","briefTitle":"A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine","officialTitle":"A Phase 3, Multicenter, Open-Label 52-Week Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-06-18","primaryCompletion":"2024-06-11","completion":"2024-06-11","firstPosted":"2020-06-18","resultsPosted":"2025-07-22","lastUpdate":"2025-07-22"},"enrollment":186,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Migraine","Episodic Migraine"],"interventions":[{"type":"DRUG","name":"Atogepant 60 mg","otherNames":[]}],"arms":[{"label":"Atogepant 60 mg Chronic Migraine","type":"EXPERIMENTAL"},{"label":"Atogepant 60 mg Episodic Migraine","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the long-term safety, efficacy and tolerability of atogepant 60 mg daily for the prevention of migraine in Japanese participants with chronic (CM) or episodic migraine (EM).","primaryOutcome":{"measure":"Percentage of Participants With at Least 1 Treatment-Emergent Adverse Event and Treatment-Emergent Serious Adverse Event (TEAEs/TESAEs)","timeFrame":"From first dose of study drug until 4 weeks following the last dose of study drug (up to 56 weeks)","effectByArm":[{"arm":"Atogepant 60 mg Chronic Migraine","deltaMin":88.4,"sd":null},{"arm":"Atogepant 60 mg Episodic Migraine","deltaMin":90.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":24,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://www.abbvieclinicaltrials.com/study/?id=3101-306-002"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":155},"commonTop":["PYREXIA","NASOPHARYNGITIS","CONSTIPATION","ALANINE AMINOTRANSFERASE INCREASED","CYSTITIS"]}}